 |
About Tequin
On May 1 2006, Bristol Myers Squibb announced that it would stop making the
antibiotic Tequin because it was linked to serious cases of diabetes and
potentially fatal blood sugar abnormalities.
Tequin (gatifloxacin) was introduced into the pharmaceutical marketplace in
1999. By the year 2001, 3.3 million prescriptions per year had being written.
Have you or a loved one been harmed from serious Tequin side effects?
Researchers began noticing health problems, particularly alterations in glucose
metabolism. Changes in blood sugar levels can induce coma and other serious
problems, including death. Tequin side effects usually began five to 10 days
after patients first started taking the drug. In most cases, the Tequin side
effects could be reversed when drug use stopped.
Tequin (generic: Gatifloxacin) is a popular antibiotic used to treat adults with
pneumonia, bronchitis, sinus problems, uncomplicated gonorrhea, and infections
of the urinary tract, kidneys, and skin. Manufactured by Bristol-Myers Squibb,
Tequin has been recently linked to dangerous and potentially fatal side effects
including hypergylcemia (high blood sugar), hypoglycemia (low blood sugar) and
diabetic ketoacidosis (severe out of control blood sugar) leading to diabetic
coma, severe liver damage, and death.
By 2003, 17 Tequin deaths had occurred and prescriptions were reduced to
approximately 1.7 million per year. Still, 1.7 million prescriptions is not
small change. The reason for such a high number is because the Department of
Veterans Affairs added the drug as its first choice antibiotic because
Bristol-Myers offered the government a price of $1.35 per pill compared to $8 to
$10 per pill, the price charged for Tequin and other fluoroquinolone antibiotics
at pharmacies. The government also chose it because the risk of glucose
abnormalities caused by gatifloxacin did not seem to be any higher than that
caused by other antibiotics in the same class.
How can I help you with a possible Tequin
lawsuit?
|
 |
 |
